Diagnosis and management of herpes simplex ocular infection
- PMID: 131786
- DOI: 10.1097/00004397-197501540-00004
Diagnosis and management of herpes simplex ocular infection
Abstract
The multifaceted nature of ocular herpes simplex has become more clearly defined in recent years, as it has become apparent that it is a disease characterized by both infectious and immune components. Therapy Therapy of infectious epithelial dendritic-geographic disease is generally gentle debridement of the ulcer followed by antimetabolite chemotherapy with IDU or Ara A. Tropic (metaherpetic) ulceration may occur postinfection and is caused by sterile basement membrane damage, which makes it difficult for the epithelium to heal across the damaged ulcer base. Therapy is generally that of recurrent erosion and involves patching, soft contact lenses, and lubricating drops and ointments. Stromal disease may be (1) viral interstitial keratitis, which is slowly responsive to antiviral therapy, or (2) immune disciform reaction, which may or (hopefully) may not necessitate steroid therapy with prophylactic antiviral and antibiotic cover. Herpetic iritis may occur alone or with any form of corneal disease. While it is generally felt to be caused by intact intraocular virus, therapy is still steroid-oriented for lack of more effective and penetrating antiviral drugs. Antimetabolite-induced medicamentosa may mimic almost any form of herpetic disease and should be ruled out in any differential diagnosis of a patient deteriorating under therapy.
Similar articles
-
The treatment of herpes simplex virus epithelial keratitis.Trans Am Ophthalmol Soc. 2000;98:505-32. Trans Am Ophthalmol Soc. 2000. PMID: 11190039 Free PMC article.
-
Prognostic indicators of herpetic keratitis. Analysis of a five-year observation period after corneal ulceration.Arch Ophthalmol. 1981 Sep;99(9):1578-82. doi: 10.1001/archopht.1981.03930020452009. Arch Ophthalmol. 1981. PMID: 6793030
-
Ara-A and IDU therapy of human superficial herpetic keratitis.Invest Ophthalmol. 1975 Oct;14(10):762-3. Invest Ophthalmol. 1975. PMID: 1102484 Clinical Trial.
-
Ocular herpes simplex virus infections.Clin Dermatol. 1984 Apr-Jun;2(2):56-66. doi: 10.1016/0738-081x(84)90066-x. Clin Dermatol. 1984. PMID: 6443690 Review. No abstract available.
-
Vidarabine therapy of complicated herpes simplex keratitis.Am J Ophthalmol. 1976 May;81(5):642-9. doi: 10.1016/0002-9394(76)90131-8. Am J Ophthalmol. 1976. PMID: 1275044
Cited by
-
Herpes simplex and herpes zoster keratouveitis: diagnosis and management.Bull N Y Acad Med. 1977 Oct;53(8):731-48. Bull N Y Acad Med. 1977. PMID: 302725 Free PMC article. No abstract available.
-
Ophthalmological complications of haemodialysis and kidney transplantation.Doc Ophthalmol. 1980 May 30;49(1):v-vii, 1-96. doi: 10.1007/BF00175176. Doc Ophthalmol. 1980. PMID: 6996976 No abstract available.
-
A rapid and sensitive culture test for detecting herpes simplex virus from the eye.Br J Ophthalmol. 1985 Sep;69(9):637-9. doi: 10.1136/bjo.69.9.637. Br J Ophthalmol. 1985. PMID: 2994709 Free PMC article.
-
Understanding the role of aldose reductase in ocular inflammation.Curr Mol Med. 2010 Aug;10(6):540-9. doi: 10.2174/1566524011009060540. Curr Mol Med. 2010. PMID: 20642441 Free PMC article. Review.
-
Adoption of Innovation in Herpes Simplex Virus Keratitis.Cornea. 2020 Nov;39 Suppl 1(1):S7-S18. doi: 10.1097/ICO.0000000000002425. Cornea. 2020. PMID: 32732703 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources